DiaSorin S.p.A. (BIT: DIA)

Market Cap	5.33B
Revenue (ttm)	1.18B
Net Income (ttm)	188.85M
Shares Out	53.32M
EPS (ttm)	3.54
PE Ratio	28.22
Forward PE	22.54
Dividend	1.15 (1.15%)
Ex-Dividend Date	n/a

Volume	52,757
Open	99.74
Previous Close	99.94
Day's Range	99.06 - 99.94
52-Week Range	82.72 - 112.35
Beta	0.16
Analysts	n/a
Price Target	n/a
Earnings Date	Mar 14, 2025

About DiaSorin

DiaSorin S.p.A. engages in development, manufacture, and distribution of immunodiagnostics and molecular diagnostics testing kits in Europe, North America, and internationally. It provides various immunodiagnostic LIAISON chemiluminescence analyzers under LIAISON XL and LIAISON XS name; and Simplexa, a congenital CMV direct kit, which detects cytomegalovirus DNA in saliva swab and urine specimens. The company was founded in 1968 and is headquartered in Saluggia, Italy.

• Industry: Medical - Diagnostics & Research
• Sector: Healthcare
• Founded: 1968
• Employees: 3,233
• Stock Exchange: Borsa Italiana
• Ticker Symbol: DIA

Financial Performance

In 2023, DiaSorin's revenue was 1.15 billion, a decrease of -15.64% compared to the previous year's 1.36 billion. Earnings were 159.85 million, a decrease of -33.65%.